Pfizer celebrates 25 years of commitment to cardiovascular health in Nigeria

Pfizer Nigeria is proud to announce its 25 years of commitment to cardiovascular health in Nigeria and the re-launch of one of its leading cardiovascular brands.

The re-launch of the brand is to create adequate awareness and differentiation based on its strong heritage of quality, efficacy and safety.

The Medical Director, Pfizer North East African Region (NEAR), Dr. Kodjo Soroh, said: “Over the course of the last 25 years, we are proud to have contributed to the advancement of knowledge and the practice of cardiovascular medicine in Nigeria. Our mission is to use innovative science to improve healthcare at every stage of life.”

Pfizer has built a tradition of excellence in addressing the growing concerns of cardiovascular diseases by organizing disease awareness programs and free medical screening for the general public. These screenings take place in pharmacies, religious organizations, corporate establishments, and also in partnership with medical institutions.

To avoid cardiovascular diseases it is necessary to undergo regular blood pressure checks, as the public health burden in Africa is changing and cardiovascular disease is increasing in prevalence.

According to Margaret Olele, Corporate Affairs/Health and Value Director, “The re-launch is also an opportunity to engage decision makers and strengthen our relationship in the medical community. We will continue to work closely with relevant stakeholders, to increase awareness on cardiovascular diseases.

“As Pfizer Nigeria celebrates this milestone, we will continue to strive for continuous improvement in our products, ensuring that our standards are never compromised. We are committed to contributing positively to the communities where we operate and set the standard for quality, safety and value of medicines.”